Quantum Biopharma (QNTM) Other Non-Current Assets (2020 - 2022)
Quantum Biopharma recorded quarterly Other Non-Current Assets of $8.8 million in Q1 2022, up 1.46% quarter-over-quarter from $8.6 million in Q4 2021, and up 0.64% year-over-year from $8.7 million in Q1 2021.
Quantum Biopharma's Other Non-Current Assets history runs 3 years deep, the most recent figure standing at $8.8 million for Q1 2022.
- In Q1 2022, Other Non-Current Assets rose 0.64% year-over-year to $8.8 million; the TTM figure through Mar 2022 stood at $8.8 million (up 0.64% YoY), while the FY2021 annual figure was $8.6 million, changed 0.43% from the prior year.
- Other Non-Current Assets came in at $8.8 million for Q1 2022 at Quantum Biopharma, up from $8.6 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $9.2 million in Q1 2020 to a low of $8.2 million in Q3 2020.
- A 3-year average of $8.7 million and a median of $8.6 million in 2021 frame the typical range for Other Non-Current Assets.
- On a YoY basis, Other Non-Current Assets climbed as much as 4.59% in 2021 and fell as far as 5.09% in 2021.
- Quantum Biopharma's Other Non-Current Assets stood at $8.6 million in 2020, then advanced by 0.43% to $8.6 million in 2021, then rose by 1.46% to $8.8 million in 2022.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $8.8 million, $8.6 million, and $8.6 million for Q1 2022, Q4 2021, and Q3 2021 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.13 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 63.55 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 4.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 8.77 Mn |
| Dec 31, 2021 | 8.65 Mn |
| Sep 30, 2021 | 8.61 Mn |
| Jun 30, 2021 | 8.85 Mn |
| Mar 31, 2021 | 8.72 Mn |
| Dec 31, 2020 | 8.61 Mn |
| Sep 30, 2020 | 8.23 Mn |
| Jun 30, 2020 | 8.60 Mn |
| Mar 31, 2020 | 9.19 Mn |